These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16757207)

  • 1. Elevated salivary endothelin levels in oral cancer patients--a pilot study.
    Pickering V; Jordan RC; Schmidt BL
    Oral Oncol; 2007 Jan; 43(1):37-41. PubMed ID: 16757207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of salivary endothelin-1 levels in oral squamous cell carcinoma and oral leukoplakia.
    Hoffmann RR; Yurgel LS; Campos MM
    Regul Pept; 2011 Jan; 166(1-3):55-8. PubMed ID: 20727373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant analysis of salivary tumor markers--a new diagnostic tool for oral cancer.
    Nagler R; Bahar G; Shpitzer T; Feinmesser R
    Clin Cancer Res; 2006 Jul; 12(13):3979-84. PubMed ID: 16818695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma.
    Rhodus NL; Ho V; Miller CS; Myers S; Ondrey F
    Cancer Detect Prev; 2005; 29(1):42-5. PubMed ID: 15734216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary lactate dehydrogenase levels in oral leukoplakia and oral squamous cell carcinoma: a biochemical and clinicopathological study.
    Shetty SR; Chadha R; Babu S; Kumari S; Bhat S; Achalli S
    J Cancer Res Ther; 2012 Jan; 8 Suppl 1():S123-5. PubMed ID: 22322730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients.
    Zhong LP; Zhang CP; Zheng JW; Li J; Chen WT; Zhang ZY
    Arch Oral Biol; 2007 Nov; 52(11):1079-87. PubMed ID: 17612501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer.
    Jou YJ; Lin CD; Lai CH; Chen CH; Kao JY; Chen SY; Tsai MH; Huang SH; Lin CW
    Anal Chim Acta; 2010 Nov; 681(1-2):41-8. PubMed ID: 21035601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased plasma and salivary cortisol levels in patients with oral cancer and their association with clinical stage.
    Bernabé DG; Tamae AC; Miyahara GI; Sundefeld ML; Oliveira SP; Biasoli ÉR
    J Clin Pathol; 2012 Oct; 65(10):934-9. PubMed ID: 22734006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary endothelin-1 potential for detecting oral cancer in patients with oral lichen planus or oral cancer in remission.
    Cheng YS; Rees T; Jordan L; Oxford L; O'Brien J; Chen HS; Wong D
    Oral Oncol; 2011 Dec; 47(12):1122-6. PubMed ID: 21868280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of salivary endothelin-1 as a biomarker for oral cancer and precancer.
    Irfan S; Zaidi N; Tiwari K; Lal N; Srivastava AN; Singh S
    J Cancer Res Ther; 2024 Jul; 20(5):1420-1424. PubMed ID: 38102911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma.
    St John MA; Li Y; Zhou X; Denny P; Ho CM; Montemagno C; Shi W; Qi F; Wu B; Sinha U; Jordan R; Wolinsky L; Park NH; Liu H; Abemayor E; Wong DT
    Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):929-35. PubMed ID: 15313862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary zinc finger protein 510 peptide as a novel biomarker for detection of oral squamous cell carcinoma in early stages.
    Jou YJ; Lin CD; Lai CH; Tang CH; Huang SH; Tsai MH; Chen SY; Kao JY; Lin CW
    Clin Chim Acta; 2011 Jul; 412(15-16):1357-65. PubMed ID: 21497587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
    G D; Nandan SRK; Kulkarni PG
    Asian Pac J Cancer Prev; 2019 Jul; 20(7):2087-2093. PubMed ID: 31350970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A metabonomic approach to the diagnosis of oral squamous cell carcinoma, oral lichen planus and oral leukoplakia.
    Yan SK; Wei BJ; Lin ZY; Yang Y; Zhou ZT; Zhang WD
    Oral Oncol; 2008 May; 44(5):477-83. PubMed ID: 17936673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MICA and MICB overexpression in oral squamous cell carcinoma.
    Liu CJ; Lui MT; Chen HL; Lin SC; Chang KW
    J Oral Pathol Med; 2007 Jan; 36(1):43-7. PubMed ID: 17181741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase activity in oral and maxillofacial tumors.
    Liao J; Mitsuyasu T; Yamane K; Ohishi M
    Oral Oncol; 2000 Jul; 36(4):347-52. PubMed ID: 10899673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of salivary interleukin 6 and tumor necrosis factor alpha in patients with oral leukoplakia.
    Brailo V; Vucićević-Boras V; Cekić-Arambasin A; Alajbeg IZ; Milenović A; Lukac J
    Oral Oncol; 2006 Apr; 42(4):370-3. PubMed ID: 16324876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical changes of saliva in tobacco chewers tobacco smokers, alcohol consumers, leukoplakia and oral cancer patients.
    Girja KP; Sundharam BS; Krishnan PA; Devi CS
    Indian J Dent Res; 2002; 13(2):102-7. PubMed ID: 12420576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretome-based identification of Mac-2 binding protein as a potential oral cancer marker involved in cell growth and motility.
    Weng LP; Wu CC; Hsu BL; Chi LM; Liang Y; Tseng CP; Hsieh LL; Yu JS
    J Proteome Res; 2008 Sep; 7(9):3765-75. PubMed ID: 18646789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statherin levels in saliva of patients with precancerous and cancerous lesions of the oral cavity: a preliminary report.
    Contucci AM; Inzitari R; Agostino S; Vitali A; Fiorita A; Cabras T; Scarano E; Messana I
    Oral Dis; 2005 Mar; 11(2):95-9. PubMed ID: 15752082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.